Pulmicort Aerosol, Powder
Product Images NDC 85612-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Pulmicort (NDC 85612-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rubicon Holdings Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (180mcg Label)

Image Description (180mcg Label)
This text provides detailed information about a medication called Pulmicort Flexhalerâ„¢ 180 meg, specifically focusing on its dosage, distribution, and instructions for use. The product is an inhalation powder containing budesonide and lactose, with each actuation delivering 160 mcg of budesonide. It is distributed by Allegis Pharmaceuticals, Inc., for Rubicon Holdings Inc. and licensed by CHEPLAPHARM Arzneimittel GmbH. The medication is trademarked as PULMICORT FLEXHALER by the AstraZeneca group of companies. The text includes guidance for both physicians and patients, emphasizing the importance of consulting the package insert for dosage information and reading the enclosed Patient Information and Instructions for Use thoroughly before use. Additionally, it advises against using the inhaler after the expiration date and provides storage instructions at a controlled room temperature.*
FDA Label Image

Image Description (90mcg Label)

Image Description (90mcg Label)
Description: The text provides detailed information about Pulmicort Flexhaler 90 meg, a medication containing budesonide inhalation powder at a strength of 90 mcg per actuation. It includes instructions for oral inhalation, details about dispensing, and storage recommendations. The text also mentions the trademark holder and manufacturing locations. Additional information includes dosage instructions for both physicians and patients, as well as precautions and storage guidelines.*
FDA Label Image

Image Description (Image 01a)

FDA Label Image

Image Description (Image 02a)

FDA Label Image

Image Description (Image 03a)

FDA Label Image

Image Description (Image 04a)

Image Description (Image 04a)
This text mentions a mouthpiece, dose indicator, and brown grip. It seems to be describing a medical device such as an inhaler or similar tool.*
FDA Label Image

Image Description (Image 05a)

FDA Label Image

Image Description (Image 06a)

FDA Label Image

Image Description (Image 07a)

FDA Label Image

Image Description (Image 08a)

FDA Label Image

Image Description (Image 09a)

FDA Label Image

Image Description (Image 10a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.